The US Food and Drug Administration (FDA) has issued a draft
guidance proposing lowering the risk classification for external
pacemaker pulse generators from Class III to Class II. The change would
remove such devices from the list of 22 remaining Class III medical
devices on the market prior to the Medical Device Amendments Act of 1976 that continue to be reviewed under the 510(k) program rather than Premarket Approval.
Read more: